Skip to main content
Figure 4 | Cardiovascular Diabetology

Figure 4

From: Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease

Figure 4

EV-markers and the risk of new onset type 2 diabetes in patients with manifest cardiovascular disease. Hazard ratios with 95% CI indicate the relative risk for incident type 2 diabetes per increase in EV-cystatin C, EV-serpin G1, EV-serpin F2 or EV-CD14 concentration during 6.5Ā years (interquartile range 5.8ā€“7.1Ā years) follow-up, adjusted for age, sex, current smoking, hsCRP, eGFR and year of inclusion in SMART.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840